T. Rowe Price Associates
ONCS

T. Rowe Price Associates’s OncoSec Medical Incorporated ONCS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,400
Closed -$54K 2988
2021
Q1
$54K Hold
11,400
﹤0.01% 2817
2020
Q4
$74K Sell
11,400
-5,660
-33% -$36.7K ﹤0.01% 2636
2020
Q3
$58K Buy
+17,060
New +$58K ﹤0.01% 2534
2019
Q2
Sell
-56,600
Closed -$32K 2575
2019
Q1
$32K Hold
56,600
﹤0.01% 2508
2018
Q4
$36K Sell
56,600
-97,000
-63% -$61.7K ﹤0.01% 2524
2018
Q3
$215K Hold
153,600
﹤0.01% 2432
2018
Q2
$212K Buy
153,600
+56,600
+58% +$78.1K ﹤0.01% 2434
2018
Q1
$182K Hold
97,000
﹤0.01% 2421
2017
Q4
$158K Buy
+97,000
New +$158K ﹤0.01% 2438